TY - JOUR A1 - Geburtig-Chiocchetti, Andreas A1 - Yousaf, Afsheen A1 - Waltes, Regina A1 - Bernhard, Anka A1 - Martinelli, Anne A1 - Ackermann, Katharina A1 - Haslinger, Denise A1 - Rotter, Björn A1 - Krezdorn, Nico A1 - Konrad, Kerstin A1 - Kohls, Gregor A1 - Vetro, Agnes A1 - Hervás, Amaia A1 - Fernández-Rivas, Aranzazu A1 - Freitag, Christine M. T1 - The methylome in females with adolescent Conduct Disorder: Neural pathomechanisms and environmental risk factors T2 - PLOS ONE N2 - Conduct Disorder (CD) is an impairing psychiatric disorder of childhood and adolescence characterized by aggressive and dissocial behavior. Environmental factors such as maternal smoking during pregnancy, socio-economic status, trauma, or early life stress are associated with CD. Although the number of females with CD is rising in Western societies, CD is under-researched in female cohorts. We aimed at exploring the epigenetic signature of females with CD and its relation to psychosocial and environmental risk factors. We performed HpaII sensitive genome-wide methylation sequencing of 49 CD girls and 50 matched typically developing controls and linear regression models to identify differentially methylated CpG loci (tags) and regions. Significant tags and regions were mapped to the respective genes and tested for enrichment in pathways and brain developmental processes. Finally, epigenetic signatures were tested as mediators for CD-associated risk factors. We identified a 12% increased methylation 5’ of the neurite modulator SLITRK5 (FDR = 0.0046) in cases within a glucocorticoid receptor binding site. Functionally, methylation positively correlated with gene expression in lymphoblastoid cell lines. At systems-level, genes (uncorr. P < 0.01) were associated with development of neurons, neurite outgrowth or neuronal developmental processes. At gene expression level, the associated gene-networks are activated perinatally and during early childhood in neocortical regions, thalamus and striatum, and expressed in amygdala and hippocampus. Specifically, the epigenetic signatures of the gene network activated in the thalamus during early childhood correlated with the effect of parental education on CD status possibly mediating its protective effect. The differential methylation patterns identified in females with CD are likely to affect genes that are expressed in brain regions previously indicated in CD. We provide suggestive evidence that protective effects are likely mediated by epigenetic mechanisms impairing specific brain developmental networks and therefore exerting a long-term effect on neural functions in CD. Our results are exploratory and thus, further replication is needed. KW - DNA methylation KW - Epigenetics KW - Methylation KW - Environmental impacts KW - Gene expression KW - Aggression KW - Genetic loci KW - Genetic networks Y1 - 2022 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/62714 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-627142 SN - 1932-6203 N1 - Data Availability: All data needed to replicate the findings is available here: https://osf.io/erqwp/ This includes the anonymized phenotypic data of probands, the epigenetics data (reads per proband matrix) and any additional files used. The code used in the analytical pipeline is available here: https://github.com/achiocch/femNATCD_MethSeq. The full outcomes of the analysis are available as git-hub page https://achiocch.github.io/femNATCD_MethSeq/ Due to ethical restrictions in the informed consent given by the study participants, raw genetic or epigenetic data (FASTQ) cannot be made publicly available. The reason is that genetic data cannot be anonymized, and is thus considered special sensitive data. However, the FASTQ dataset is not part of the minimal data set and not needed to replicated the analyses and conclusions made. N1 - Funding: This project has been funded by the European FP7 Framework, grant agreement no: 602407, FemNAT-CD (coordinator CM Freitag). The funder provided support in the form of salaries for authors [AGC, AB, AM, KA] as well as for the methylation analysis at geneXpro and other consumables. VL - 17 IS - 1, art. e0261691 SP - 1 EP - 17 PB - PLOS CY - San Francisco, California, US ER -